Back to Top
Indusatumab Vedotin Biosimilar - Research Grade
Add recommended extras
Indusatumab Vedotin Biosimilar - Research Grade
| Species Reactivity | Human |
|---|---|
| Target | GUCY2C |
| Concentration | 1mg/ml |
| Isotype | IgG1 |
| Host | CHO Cells |
| Shipping Conditions | Room Temp |
| background | Indusatumab vedotin is an antibody-drug conjugate that is under development for the treatment of pancreatic cancer and other gastrointestinal cancers. It consists of a monoclonal antibody (indusatumab) that targets the enzyme guanylate cyclase 2C which i |
| Other names | MMAE |
| Formulation | 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) |
| Purity | >90% by SDS-PAGE |
| Storage | This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C. |
| Applications | Functional Assays |
| Application Notes | Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex. |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Delivery Time | 1 week |
Write Your Own Review


















